Meeting
2022 ASCO Annual Meeting
EA2201: An ECOG-ACRIN phase II study of neoadjuvant nivolumab plus ipilimumab and short course radiation in MSI-H/dMMR rectal tumors.
Authors
Kristen Keon Ciombor
Vanderbilt University Medical Center, Nashville, TN
Kristen Keon Ciombor , Sung Chul Hong , Cathy Eng , Xin Yao , May Thet Cho , Y. Nancy You , Prajnan Das , Anuradha Bapsi Chakravarthy , Peter J. O'Dwyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer - Neo-Adjuvant/Adjuvant
Clinical Trial Registration Number
NCT04751370
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS3644)
DOI
10.1200/JCO.2022.40.16_suppl.TPS3644
Abstract #
TPS3644
Poster Bd #
430a
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).
First Author: Giacomo Bregni
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Relationship between the number of positive MSI markers and the efficacy of NIVO+IPI therapy in MSI-H gastric cancer: A subgroup analysis of NO LIMIT study (WJOG13320G/CA209-7W7).
First Author: Kenro Hirata
Poster
2022 ASCO Annual Meeting
Neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant early-stage triple-negative breast cancer (TNBC): A single-arm phase 2 trial.
First Author: Sherene Loi
Poster
2020 ASCO Virtual Scientific Program
Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
First Author: Satoshi Yuki